Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Capital Expenditures (2016 - 2024)

Historic Capital Expenditures for Biomerica (BMRA) over the last 15 years, with Q2 2024 value amounting to $24000.0.

  • Biomerica's Capital Expenditures changed N/A to $24000.0 in Q2 2024 from the same period last year, while for May 2024 it was $51000.0, marking a year-over-year decrease of 2031.25%. This contributed to the annual value of $51000.0 for FY2024, which is 2031.25% down from last year.
  • As of Q2 2024, Biomerica's Capital Expenditures stood at $24000.0.
  • Biomerica's Capital Expenditures' 5-year high stood at $45194.0 during Q1 2021, with a 5-year trough of $5141.0 in Q3 2021.
  • For the 5-year period, Biomerica's Capital Expenditures averaged around $20946.3, with its median value being $21689.5 (2020).
  • As far as peak fluctuations go, Biomerica's Capital Expenditures skyrocketed by 172349.15% in 2020, and later crashed by 8701.37% in 2021.
  • Quarter analysis of 5 years shows Biomerica's Capital Expenditures stood at $21978.0 in 2020, then crashed by 40.53% to $13071.0 in 2021, then surged by 83.61% to $24000.0 in 2022, then crashed by 75.0% to $6000.0 in 2023, then soared by 300.0% to $24000.0 in 2024.
  • Its Capital Expenditures stands at $24000.0 for Q2 2024, versus $6000.0 for Q4 2023 and $21000.0 for Q3 2023.